Differential expression of lymphoid and myeloid markers on differentiating hematopoietic stem cells in normal and tumor-bearing adult human liver

Hepatology

Volumn 31, Issue 6, 2000, Pages 1251-1256

  Golden Mason, Lucy ^a,b   Curry, Michael P ^a   Nolan, Niamh ^a   Traynor, Oscar ^a   McEntee, Gerry ^a   Kelly, Jacinta ^b   Hegarty, John E ^a   O'Farrelly, Cliona ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CD7 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; COLON CANCER; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CANCER; LIVER METASTASIS; MALE; METASTASIS; PHENOTYPE; PRIORITY JOURNAL;

EID: 0034038462     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.7713     Document Type: Article

References (13)

1. Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR, Fanger NA. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRIAL. J Exp Med 1999;189:1343-1353.
2. Zhang W, Arii S, Sasaoki T, Adachi Y, Funak N, Higashitsuji H, Fujita S, et al. The role of Kupffer cells in the surveillance of tumor growth in the liver. J Surg Res 1993;55:140-146.
3. Heuff G, Oldenburg HS, Boutkan H, Visser JJ, Beelen RH, Van Rooijen N, Dijkstra CD, et al. Enhanced tumor growth in the rat liver after selective elimination of Kupffer cells. HEPATOLOGY 1995;21:740-745.
4. Musiani P, Allione A, Modica A, Lollini PL, Giovarelli M, Cavallo F, Belardelli F, et al. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. Lab Invest 1996;74:146-157.
5. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
6. Hashimoto W, Takeda K, Anzai R, Ogasawara K, Sakihara H, Sugiura K, Seki S, et al. Cytotoxic NK1.1 ag4- αβ T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 1995;154:4333-4340.
7. Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, Kaneko Y, et al. Requirement for Vα14 NKT cells in IL-12 mediated rejection of tumors. Science 1997;278:1623-1629.
8. Kurosawa S, Harada M, Matsuzaki G, Shinomiya Y, Terao H, Kobayashi N, Nomoto K. Early-appearing tumor-infiltrating natural killer cells play a critical role in the generation of anti-tumor T lymphocytes. Immunology 1995;85:338-346.
9. Xiang R, Lode NN, Dolman CS, Dreier T, Varki NM, Qian X, Lo K-M, et al. Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy. Cancer Res 1997;57:4948-4955.
10. Whiteside T, Heberman RB. The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol 1995;7:704-710.
11. Kawamura T, Kawachi Y, Moroda T, Weerashinghe A, Seki S, Takada G, Abo T. Cytotoxic activity against tumor cells mediated by intermediate TCR cells in the liver and spleen. Immunology 1996;89:68-75.
12. Ohmori K, liai T, Watanabe H, Tanaka T, Miyasaka M, Abo T. Activation of extrathymic T cells in the liver of mice bearing syngenic tumors. Biomed Res 1993;14:65-79.
13. Hann IM, Bodger MP, Hoffbrand AV. Development of pluripotent hematopoietic progenitor cells in the human fetus. Blood 1983;62:118-123.